Abstract
Cutaneous manifestations are common in primary immune deficiency diseases, affecting between 40 % and 70 % of patients with diagnosed primary immune deficiency. Skin infections characterize many primary immune deficiencies, but there are also frequent noninfectious cutaneous manifestations seen in many of these disorders, including eczematous lesions, erythroderma, cutaneous granulomas, dysplasia of skin, hair, and nails, autoimmune conditions, and frank vasculitis. For the patient with suspected primary immunodeficiency, much can be inferred by evaluating the presenting cutaneous findings, including various infectious susceptibilities, presence of atopy, and evidence of impaired or overactive inflammatory response. The skin manifestations of primary immune deficiency diseases are often early or heralding findings of the underlying immunologic disease. Therefore, awareness of associations between skin findings and immune deficiency may aide in the early detection and treatment of serious or life-threatening immunologic defects. This review summarizes the common skin manifestations of primary immune deficiency diseases and provides the reader with a differential diagnosis of primary immune defects to consider for the most common skin manifestations.
Similar content being viewed by others
References
Al-Herz W, Bousfiha A, Casanova JL, Chapel H, Conley ME, Cunningham-Rundles C et al (2011) Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency. Front Immunol 2:54
Berron-Ruiz A, Berron-Perez R, Ruiz-Maldonado R (2000) Cutaneous markers of primary immunodeficiency diseases in children. Pediatr Dermatol 17:91–96
Moin A, Farhoudi A, Moin M, Pourpak Z, Bazargan N (2006) Cutaneous manifestations of primary immunodeficiency diseases in children. Iran J Allergy Asthma Immunol 5:121–126
Al-Herz W, Nanda A (2011) Skin manifestations in primary immunodeficient children. Pediatr Dermatol 28:494–501
Joshi AY, Iyer VN, Hagan JB, St Sauver JL, Boyce TG (2009) Incidence and temporal trends of primary immunodeficiency: a population-based cohort study. Mayo Clin Proc 84:16–22
Stinchcombe J, Bossi G, Griffiths GM (2004) Linking albinism and immunity: the secrets of secretory lysosomes. Science 305:55–59
Boxer LA, Newburger PE (2007) A molecular classification of congenital neutropenia syndromes. Pediatr Blood Cancer 49:609–614
Fontana S, Parolini S, Vermi W, Booth S, Gallo F, Donini M et al (2006) Innate immunity defects in Hermansky-Pudlak type 2 syndrome. Blood 107:4857–4864
Enders A, Zieger B, Schwarz K, Yoshimi A, Speckmann C, Knoepfle EM et al (2006) Lethal hemophagocytic lymphohistiocytosis in Hermansky-Pudlak syndrome type II. Blood 108:81–87
Spritz RA (1999) Multi-organellar disorders of pigmentation: tied up in traffic. Clin Genet 55:309–317
Shaw TE, Currie GP, Koudelka CW, Simpson EL (2011) Eczema prevalence in the United States: data from the 2003 National Survey of Children’s Health. J Invest Dermatol 131:67–73
Chu EY, Freeman AF, Jing H, Cowen EW, Davis J, Su HC et al (2012) Cutaneous manifestations of DOCK8 deficiency syndrome. Arch Dermatol 148:79–84
Freeman AF, Holland SM (2009) Clinical manifestations, etiology, and pathogenesis of the hyper-IgE syndromes. Pediatr Res 65:32R–37R
Sullivan KE, Mullen CA, Blaese RM, Winkelstein JA (1994) A multiinstitutional survey of the Wiskott-Aldrich syndrome. J Pediatr 125:876–885
Powell BR, Buist NR, Stenzel P (1982) An X-linked syndrome of diarrhea, polyendocrinopathy, and fatal infection in infancy. J Pediatr 100:731–737
Marrella V, Maina V, Villa A (2011) Omenn syndrome does not live by V(D)J recombination alone. Curr Opin Allergy Clin Immunol 11:525–531
Chavanas S, Bodemer C, Rochat A, Hamel-Teillac D, Ali M, Irvine AD et al (2000) Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome. Nat Genet 25:141–142
Renner ED, Hartl D, Rylaarsdam S, Young ML, Monaco-Shawver L, Kleiner G et al (2009) Comel-Netherton syndrome defined as primary immunodeficiency. J Allergy Clin Immunol 124:536–543
Sehgal VN, Srivastava G, Sardana K (2004) Erythroderma/exfoliative dermatitis: a synopsis. Int J Dermatol 43:39–47
Al-Dhalimi MA (2007) Neonatal and infantile erythroderma: a clinical and follow-up study of 42 cases. J Dermatol 34:302–307
Hoeger PH, Harper JI (1998) Neonatal erythroderma: differential diagnosis and management of the “red baby”. Arch Dis Child 79:186–191
Traupe H (1989) The Comèl–Netherton syndrome. The Ichthyoses: Springer Berlin, Heidelberg, pp 168–178
de Saint-Basile G, Le Deist F, de Villartay JP, Cerf-Bensussan N, Journet O, Brousse N et al (1991) Restricted heterogeneity of T lymphocytes in combined immunodeficiency with hypereosinophilia (Omenn’s syndrome). J Clin Invest 87:1352–1359
Le Deist F, Raffoux C, Griscelli C, Fischer A (1987) Graft vs graft reaction resulting in the elimination of maternal cells in a SCID patient with maternofetal GVHd after an HLA identical bone marrow transplantation. J Immunol 138:423–427
Anderson KC, Weinstein HJ (1990) Transfusion-associated graft-versus-host disease. N Engl J Med 323:315–321
Wen L, Atkinson JP, Giclas PC (2004) Clinical and laboratory evaluation of complement deficiency. J Allergy Clin Immunol 113:585–593, quiz 594
Arunachalam M, Sanzo M, Lotti T, Colucci R, Berti S, Moretti S (2010) Common variable immunodeficiency in vitiligo. G Ital Dermatol Venereol 145:783–788
Spickett G, Prentice AG, Wallington T, Webster AD, Chapel H (1991) Alopecia totalis and vitiligo in common variable immunodeficiency. Postgrad Med J 67:291–294
Koskinen S (1996) Long-term follow-up of health in blood donors with primary selective IgA deficiency. J Clin Immunol 16:165–170
Ahonen P, Myllarniemi S, Sipila I, Perheentupa J (1990) Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients. N Engl J Med 322:1829–1836
Dupuis-Girod S, Medioni J, Haddad E, Quartier P, Cavazzana-Calvo M, Le Deist F et al (2003) Autoimmunity in Wiskott-Aldrich syndrome: risk factors, clinical features, and outcome in a single-center cohort of 55 patients. Pediatrics 111:e622–e627
Catucci M, Castiello MC, Pala F, Bosticardo M, Villa A (2012) Autoimmunity in wiskott-Aldrich syndrome: an unsolved enigma. Front Immunol 3:209
Dohil M, Prendiville JS, Crawford RI, Speert DP (1997) Cutaneous manifestations of chronic granulomatous disease. A report of four cases and review of the literature. J Am Acad Dermatol 36:899–907
Cunningham-Rundles C, Bodian C (1999) Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol 92:34–48
Fasano MB, Sullivan KE, Sarpong SB, Wood RA, Jones SM, Johns CJ et al (1996) Sarcoidosis and common variable immunodeficiency. Report of 8 cases and review of the literature. Medicine (Baltimore) 75:251–261
Warnatz K, Denz A, Drager R, Braun M, Groth C, Wolff-Vorbeck G et al (2002) Severe deficiency of switched memory B cells (CD27(+)IgM(−)IgD(−)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease. Blood 99:1544–1551
Piqueras B, Lavenu-Bombled C, Galicier L, Bergeron-van der Cruyssen F, Mouthon L, Chevret S et al (2003) Common variable immunodeficiency patient classification based on impaired B cell memory differentiation correlates with clinical aspects. J Clin Immunol 23:385–400
Sanchez-Ramon S, Radigan L, Yu JE, Bard S, Cunningham-Rundles C (2008) Memory B cells in common variable immunodeficiency: clinical associations and sex differences. Clin Immunol 128:314–321
Collins SM, Dominguez M, Ilmarinen T, Costigan C, Irvine AD (2006) Dermatological manifestations of autoimmune polyendo-crinopathy–candidiasis–ectodermal dystrophy syndrome. Br J Dermatol 154:1088–1093
Hanson EP, Monaco-Shawver L, Solt LA, Madge LA, Banerjee PP, May MJ et al (2008) Hypomorphic nuclear factor-kappaB essential modulator mutation database and reconstitution system identifies phenotypic and immunologic diversity. J Allergy Clin Immunol 122(1169–1177):e1116
Courtois G, Smahi A, Reichenbach J, Doffinger R, Cancrini C, Bonnet M et al (2003) A hypermorphic IkappaBalpha mutation is associated with autosomal dominant anhidrotic ectodermal dysplasia and T cell immunodeficiency. J Clin Invest 112:1108–1115
Notarangelo LD, Roifman CM, Giliani S (2008) Cartilage-hair hypoplasia: molecular basis and heterogeneity of the immunological phenotype. Curr Opin Allergy Clin Immunol 8:534–539
Savage SA, Bertuch AA (2010) The genetics and clinical manifestations of telomere biology disorders. Genet Med 12:753–764
Dokal I (2011) Dyskeratosis congenita. Hematol Am Soc Hematol Educ Program 2011:480–486
Knight SW, Heiss NS, Vulliamy TJ, Aalfs CM, McMahon C, Richmond P et al (1999) Unexplained aplastic anaemia, immunodeficiency, and cerebellar hypoplasia (Hoyeraal-Hreidarsson syndrome) due to mutations in the dyskeratosis congenita gene, DKC1. Br J Haematol 107:335–339
Toomes C, James J, Wood AJ, Wu CL, McCormick D, Lench N et al (1999) Loss-of-function mutations in the cathepsin C gene result in periodontal disease and palmoplantar keratosis. Nat Genet 23:421–424
Winkelstein JA, Marino MC, Johnston RB Jr, Boyle J, Curnutte J, Gallin JI et al (2000) Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore) 79:155–169
Windhorst DB, Good RA (1971) Dermatologic manifestations of fatal granulomatous disease of childhood. Arch Dermatol 103:351–357
Nord KM, Pappert AS, Grossman ME (2011) Pyoderma gangrenosum-like lesions in leukocyte adhesion deficiency I treated with intravenous immunoglobulin. Pediatr Dermatol 28:156–161
Hinze CH, Lucky AW, Bove KE, Marsh RA, Bleesing JH, Passo MH (2010) Leukocyte adhesion deficiency type 1 presenting with recurrent pyoderma gangrenosum and flaccid scarring. Pediatr Dermatol 27:500–503
Paller AS, Nanda V, Spates C, O’Gorman M (1994) Leukocyte adhesion deficiency: recurrent childhood skin infections. J Am Acad Dermatol 31:316–319
Buckley RH (2001) The hyper-IgE syndrome. Clin Rev Allergy Immunol 20:139–154
Renner ED, Puck JM, Holland SM, Schmitt M, Weiss M, Frosch M et al (2004) Autosomal recessive hyperimmunoglobulin E syndrome: a distinct disease entity. J Pediatr 144:93–99
Reichenbach J, Rosenzweig S, Doffinger R, Dupuis S, Holland SM, Casanova JL (2001) Mycobacterial diseases in primary immunodeficiencies. Curr Opin Allergy Clin Immunol 1:503–511
Antaya RJ, Gardner ES, Bettencourt MS, Daines M, Denise Y, Uthaisangsook S et al (2001) Cutaneous complications of BCG vaccination in infants with immune disorders: two cases and a review of the literature. Pediatr Dermatol 18:205–209
Holland SM (2010) Chronic granulomatous disease. Clin Rev Allergy Immunol 38:3–10
Engelhardt KR, Grimbacher B (2012) Mendelian traits causing susceptibility to mucocutaneous fungal infections in human subjects. J Allergy Clin Immunol 129:294–305, quiz 306–297
Al Khatib S, Keles S, Garcia-Lloret M, Karakoc-Aydiner E, Reisli I, Artac H et al (2009) Defects along the T(H)17 differentiation pathway underlie genetically distinct forms of the hyper IgE syndrome. J Allergy Clin Immunol 124:342–348, 348 e341-345
Puel A, Cypowyj S, Marodi L, Abel L, Picard C, Casanova JL (2012) Inborn errors of human IL-17 immunity underlie chronic mucocutaneous candidiasis. Curr Opin Allergy Clin Immunol 12:616–622
Ferwerda B, Ferwerda G, Plantinga TS, Willment JA, van Spriel AB, Venselaar H et al (2009) Human dectin-1 deficiency and mucocutaneous fungal infections. N Engl J Med 361:1760–1767
Liu L, Okada S, Kong XF, Kreins AY, Cypowyj S, Abhyankar A et al (2011) Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis. J Exp Med 208:1635–1648
van de Veerdonk FL, Plantinga TS, Hoischen A, Smeekens SP, Joosten LA, Gilissen C et al (2011) STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis. N Engl J Med 365:54–61
Drewniak AA, Gazendam RP, Tool AT, van Houdt M, Jansen MH, van Hamme JL et al (2013) Invasive fungal infection and impaired neutrophil killing in human CARD9 deficiency. Blood 121:2385-2392
Glocker EO, Hennigs A, Nabavi M, Schaffer AA, Woellner C, Salzer U et al (2009) A homozygous CARD9 mutation in a family with susceptibility to fungal infections. N Engl J Med 361:1727–1735
Puel A, Doffinger R, Natividad A, Chrabieh M, Barcenas-Morales G, Picard C et al (2010) Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I. J Exp Med 207:291–297
Chatzipanagiotou S, Takou K, Perogamvros A (1998) Cutaneous purulent aspergillosis in a young man with chronic granulomatous disease. Mycoses 41:379–382
Zhang Q, Davis JC, Lamborn IT, Freeman AF, Jing H, Favreau AJ et al (2009) Combined immunodeficiency associated with DOCK8 mutations. N Engl J Med 361:2046–2055
Ramoz N, Rueda LA, Bouadjar B, Montoya LS, Orth G, Favre M (2002) Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis. Nat Genet 32:579–581
Hernandez PA, Gorlin RJ, Lukens JN, Taniuchi S, Bohinjec J, Francois F et al (2003) Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease. Nat Genet 34:70–74
Acknowledgments
The author would like to thank Dr. Steven M. Holland for the use of his image for Fig. 4.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lehman, H. Skin Manifestations of Primary Immune Deficiency. Clinic Rev Allerg Immunol 46, 112–119 (2014). https://doi.org/10.1007/s12016-013-8377-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12016-013-8377-8